These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 24795253

  • 1. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R.
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [Abstract] [Full Text] [Related]

  • 2. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G, Vicennati V, Rinaldi E, Morselli-Labate AM, Giampalma E, Mosconi C, Pagotto U, Pasquali R.
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [Abstract] [Full Text] [Related]

  • 3. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W.
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [Abstract] [Full Text] [Related]

  • 4. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [Abstract] [Full Text] [Related]

  • 5. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 6. Development of overt Cushing's syndrome in patients with adrenal incidentaloma.
    Barzon L, Fallo F, Sonino N, Boscaro M.
    Eur J Endocrinol; 2002 Jan; 146(1):61-6. PubMed ID: 11751069
    [Abstract] [Full Text] [Related]

  • 7. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J, Kjellman M, Wahrenberg H, Falhammar H.
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [Abstract] [Full Text] [Related]

  • 8. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D, ElAsmar N, Arafah BM.
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [Abstract] [Full Text] [Related]

  • 9. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
    Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
    [Abstract] [Full Text] [Related]

  • 10. Subclinical Cushing's syndrome.
    Reincke M.
    Endocrinol Metab Clin North Am; 2000 Mar; 29(1):43-56. PubMed ID: 10732263
    [Abstract] [Full Text] [Related]

  • 11. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G, Allasino B, Bovio S, Saba L, Ardito A, Angeli A, Terzolo M.
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [Abstract] [Full Text] [Related]

  • 12. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
    Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, Takeshita K, Takahara S, Nakagawa M, Fujimura Y, Kudo T, Miyajima S, Taira H, Ohe K, Ishii T, Yanase T, Kobayashi K.
    Intern Med; 2018 Sep 01; 57(17):2467-2472. PubMed ID: 29709936
    [Abstract] [Full Text] [Related]

  • 13. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
    Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I.
    Clin Endocrinol (Oxf); 2009 May 01; 70(5):674-9. PubMed ID: 19067718
    [Abstract] [Full Text] [Related]

  • 14. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May 01; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 15. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE.
    J Endocrinol Invest; 2019 Dec 01; 42(12):1435-1442. PubMed ID: 31456173
    [Abstract] [Full Text] [Related]

  • 16. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
    Mazzuco TL, Bourdeau I, Lacroix A.
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun 01; 16(3):203-10. PubMed ID: 19390321
    [Abstract] [Full Text] [Related]

  • 17. Six controversial issues on subclinical Cushing's syndrome.
    Chiodini I, Albani A, Ambrogio AG, Campo M, De Martino MC, Marcelli G, Morelli V, Zampetti B, Colao A, Pivonello R, ABC Group.
    Endocrine; 2017 May 01; 56(2):262-266. PubMed ID: 27406391
    [Abstract] [Full Text] [Related]

  • 18. [Subclinical Cushing's syndrome in adrenal incidentalomas].
    Bovio S, Reimondo G, Daffara F, Allasino B, Angeli A, Terzolo M.
    Recenti Prog Med; 2006 Jan 01; 97(1):6-15. PubMed ID: 16535924
    [Abstract] [Full Text] [Related]

  • 19. [Retrospective hormonal analysis of incidentally discovered and operated adrenal tumors for subclinical Cushing's syndrome].
    Przybylik-Mazurek E, Buziak-Bereza M, Fedorowicz A, Kuźniarz-Rymarz S, Stochmal E, Hubalewska-Dydejczyk A.
    Przegl Lek; 2010 Jan 01; 67(12):1270-5. PubMed ID: 21591352
    [Abstract] [Full Text] [Related]

  • 20. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.
    Hirsch D, Shimon I, Manisterski Y, Aviran-Barak N, Amitai O, Nadler V, Alboim S, Kopel V, Tsvetov G.
    Endocrine; 2018 Dec 01; 62(3):712-720. PubMed ID: 30084101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.